Items where contributor is "Hardmeier, Martin"
2015Hatz, F. and Hardmeier, M. and Bousleiman, H. and Rüegg, S. and Schindler, C. and Fuhr, P.. (2015) Reliability of fully automated versus visually controlled pre- and post-processing of resting-state EEG. Clinical neurophysiology, Vol. 126, H. 2. pp. 268-274. Zimmermann, R. and Gschwandtner, U. and Hatz, F. and Schindler, C. and Bousleiman, H. and Meyer, A. and Calabrese, P. and Fuhr, P.. (2015) Correlation of EEG slowing with cognitive domains in nondemented patients with Parkinson's disease. Dementia and Geriatric Cognitive Disorders, 39 (3-4). pp. 207-214. 2014Benz, Nina and Hatz, Florian and Bousleiman, Habib and Ehrensperger, Michael M. and Gschwandtner, Ute and Hardmeier, Martin and Ruegg, Stephan and Schindler, Christian and Zimmermann, Ronan and Monsch, Andreas Urs and Fuhr, Peter. (2014) Slowing of EEG background activity in Parkinson's and Alzheimer's disease with early cognitive dysfunction. Frontiers in aging neuroscience, 6. p. 314. 2013Hatz, F. and Benz, N. and Hardmeier, M. and Zimmermann, R. and Rueegg, S. and Schindler, C. and Miserez, A. R. and Gschwandtner, U. and Monsch, A. U. and Fuhr, P.. (2013) Quantitative EEG and apolipoprotein E-genotype improve classification of patients with suspected Alzheimer's disease. Clinical Neurophysiology, 124 (11). pp. 2146-2152. 2012Hardmeier, M. and Zimmermann, R. and Rüegg, S. and Pflüger, M. and Deuster, S. and Suter, K. and Donzelli, M. and Drewe, J. and Krähenbühl, S. and Fuhr, P. and Haschke, M.. (2012) Intranasal midazolam: pharmacokinetics and pharmacodynamics assessed by quantitative EEG in healthy volunteers. Clinical Pharmacology & Therapeutics, 91 (5). pp. 856-862. |
